ClinConnect ClinConnect Logo
Search / Trial NCT05997706

Unraveling the Klinefelter's Disease Physiopathology

Launched by CLINIQUES UNIVERSITAIRES SAINT-LUC- UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Aug 11, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Klinefelter Syndrome Fertility Preservation, Male

ClinConnect Summary

This clinical trial is focused on understanding Klinefelter Syndrome (KS), a genetic condition in males caused by an extra X chromosome. This condition is often linked to infertility, particularly the inability to produce sperm, known as azoospermia. Researchers will take special cells from the testes of KS patients and use a lab technique called an organoid model to study how these cells behave when mixed with different types of supporting cells. The goal is to find out how these interactions might affect fertility in men with KS.

The trial is currently looking for male participants aged 18 to 26 who have been diagnosed with Klinefelter Syndrome. Unfortunately, men with a specific variation of Klinefelter Syndrome known as mosaicism cannot participate. If you join the study, you will help researchers gain insights that could lead to better treatments for infertility related to Klinefelter Syndrome. This is an important step in understanding how to support men with this condition in their journey towards fatherhood.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Klinefelter
  • Exclusion Criteria:
  • Mosaicism

About Cliniques Universitaires Saint Luc Université Catholique De Louvain

Cliniques Universitaires Saint-Luc, affiliated with the Université Catholique de Louvain, is a leading academic medical center in Belgium dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, it focuses on a wide range of therapeutic areas, prioritizing patient safety and ethical standards. The institution is committed to fostering collaboration between researchers and clinicians to enhance medical knowledge and improve treatment outcomes, contributing significantly to the global scientific community and the advancement of evidence-based medicine.

Locations

Brussels, , Belgium

Patients applied

0 patients applied

Trial Officials

Christine Wyns, MD, PhD

Principal Investigator

Cliniques Universitaires St Luc

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported